VolumeVol. 53 • Number No. 4 • October - December 2015 Back
Clinical Trials
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0
International License, which permits use, share — copy and redistribute the material in any medium or format,
adapt — remix, transform, and build upon the material, as long as you give appropriate credit,
provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner,
but not in any way that suggests the licensor endorses you or your use. You may not use the material for
commercial purposes. If you remix, transform, or build upon the material, you must distribute your
contributions under the same license as the original. You may not apply legal terms or technological
measures that legally restrict others from doing anything the license permits. The images or other
third party material in this article are included in the article’s Creative Commons license, unless indicated
otherwise in a credit line to the material. If material is not included in the article’s Creative Commons
license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder. To view a copy of this license,
visit https://creativecommons.org/licenses/by-nc-sa/4.0/.
The Effects of Malunggay (Moringa oleifera) Leaves Capsule Supplements on High Specificity C-Reactive Protein and Hemoglobin A1c Levels of Diabetic Patients in Ospital ng Maynila Medical Center: A Prospective Cohort Study
Authors: Ranier Nery Mozo, Imelda Caole-Ang
DOI: 10.65564/pjim.2ef99d2177
Date of Publication: December 2015
More Details
Authors and Affiliations:
Ranier Nery Mozo, M.D.*; Imelda Caole-Ang, M.D.**
*Ospital ng Maynila Medical Center
Corresponding author: Rainier Nery Mozo, MD, Ospital ng Maynila Medical Center, President Quirino Avenue, Roxas Boulevard, Malate Manila
Email: [email protected]
License
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0
International License, which permits use, share — copy and redistribute the material in any medium or format,
adapt — remix, transform, and build upon the material, as long as you give appropriate credit,
provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner,
but not in any way that suggests the licensor endorses you or your use. You may not use the material for
commercial purposes. If you remix, transform, or build upon the material, you must distribute your
contributions under the same license as the original. You may not apply legal terms or technological
measures that legally restrict others from doing anything the license permits. The images or other
third party material in this article are included in the article’s Creative Commons license, unless indicated
otherwise in a credit line to the material. If material is not included in the article’s Creative Commons
license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder. To view a copy of this license,
visit https://creativecommons.org/licenses/by-nc-sa/4.0/.